Frontiers in Pharmacology: Review Manuscript Targeting of the Neutrophil as an Adjunctive Strategy in Non-Small Cell Lung Cancer
Lung cancer remains the leading cause of cancer mortality in the United States, with non-small cell lung cancer (NSCLC) accounting for around 85% of cases. Of particular concern is the poor responsiveness of this malignancy to therapy, resulting in a very low 5-year survival rate (17.4%) and a promi...
Saved in:
Main Authors: | Ronald Anderson (Author), Ada Gabriela Blidner (Author), Bernardo Leon Rapoport (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in Cancer
by: Bernardo L. Rapoport, et al.
Published: (2021) -
Contrasting Immunopathogenic and Therapeutic Roles of Granulocyte Colony-Stimulating Factor in Cancer
by: Annette J. Theron, et al.
Published: (2020) -
Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
by: Boris V. Chernyak, et al.
Published: (2021) -
Leading Cities A Global Review of City Leadership
by: Rapoport, Elizabeth
Published: (2019) -
Leading Cities A Global Review of City Leadership
by: Rapoport, Elizabeth
Published: (2019)